Talaporfin sodium
Modify Date: 2025-08-26 10:08:01
Talaporfin sodium structure
|
Common Name | Talaporfin sodium | ||
|---|---|---|---|---|
| CAS Number | 220201-34-3 | Molecular Weight | 799.688 | |
| Density | N/A | Boiling Point | 1175.5ºC at 760mmHg | |
| Molecular Formula | C38H37N5Na4O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 664.7ºC | |
Use of Talaporfin sodiumTalaporfin (ME2906; NPe6) is a photosensitizer used in photodynamic therapy (PDT).Target: OthersTalaporfin is a photosensitizer used in photodynamic therapy (PDT). Talaporfin absorbs red light at 664 nm normally provided by a laser tuned to this wavelength [1]. Talaporfin was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin [2]. |
| Name | tetrasodium,(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate |
|---|---|
| Synonym | More Synonyms |
| Description | Talaporfin (ME2906; NPe6) is a photosensitizer used in photodynamic therapy (PDT).Target: OthersTalaporfin is a photosensitizer used in photodynamic therapy (PDT). Talaporfin absorbs red light at 664 nm normally provided by a laser tuned to this wavelength [1]. Talaporfin was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin [2]. |
|---|---|
| Related Catalog | |
| References |
[1]. http://journals.lww.com/jto/Fulltext/2006/06000/Photodynamic_Therapy__PDT__for_Lung_Cancers.18.aspx [2]. http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/7229 |
| Boiling Point | 1175.5ºC at 760mmHg |
|---|---|
| Molecular Formula | C38H37N5Na4O9 |
| Molecular Weight | 799.688 |
| Flash Point | 664.7ºC |
| Exact Mass | 799.218201 |
| PSA | 245.92000 |
| Vapour Pressure | 0mmHg at 25°C |
| Storage condition | 2-8℃ |
| L-Aspartic acid, N-(((7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl)acetyl)-, tetrasodium salt |
| Aptocine |
| Mono-L-aspartyl chlorin e6 |
| Laserphyrin |
| Tetrasodium (2S)-2-((((7S,8S)-3-carboxylato-7-(2-carboxylatoethyl)-13-ethenyl-18-ethyl-2,8,12,17-tetramethyl-7,8-dihydroporphyrin-5-yl)acetyl)amino)butanedioate |
| Taporfin sodium |
| Talaporfin sodium |
| TalaporfinsodiuMsalt |
| L-Aspartic acid, N-[2-[(7S,8S)-3-carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetyl]-, sodium salt (1:4) |
| Tetrasodium (2S)-2-({[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-12-ethyl-2,8,13,18-tetramethyl-17-vinyl-2,3-dihydro-5-porphyrinyl]acetyl}amino)succinate |
| mono-L-aspartin-chlorin e6 |
| UNII:L63605PZ70 |
| LS-11 |
| talaporphin sodium |
| Tetrasodium (2S)-2-[[[(7S,8S)-3-carboxylato-7-(2-carboxylatoethyl)-13-ethenyl-18-ethyl-2,8,12,17-tetramethyl-7,8-dihydroporphyrin-5-yl]acetyl]amino]butanedioate |
| NPe6 |
| mono-L-aspartyl chlorin e6 tetrasodium salt |
| (+)-tetrasodium (2S,3S)-18-carboxylato-20-[N-(S)-1,2-dicarboxylatoethyl]-carbamoylmethyl-13-ethyl-3,7,12,17-tetramethyl-8-vinylchlorin-2-propanoate |
| Laserphyrin (TN) |
| Tetrasodium (2S)-2-({[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-12-ethyl-2,8,13,18-tetramethyl-17-vinyl-2,3-dihydroporphyrin-5-yl]acetyl}amino)succinate |
| Talaporfin (sodium) |